Piguet, V., Blauvelt, A., Burge, D., Peterson, L., Drew, J., Rolleri, R. and Weglowska, J. 2017. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT). SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s3. DOI:https://doi.org/10.25251/skin.1.supp.2.